IDEAYA Biosciences (IDYA) Net Income towards Common Stockholders (2020 - 2025)
Historic Net Income towards Common Stockholders for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to -$94.6 million.
- IDEAYA Biosciences' Net Income towards Common Stockholders rose 3438.93% to -$94.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 million, marking a year-over-year increase of 10424.56%. This contributed to the annual value of -$159.3 million for FY2025, which is 5127.67% up from last year.
- As of Q4 2025, IDEAYA Biosciences' Net Income towards Common Stockholders stood at -$94.6 million, which was up 3438.93% from $108.5 million recorded in Q3 2025.
- In the past 5 years, IDEAYA Biosciences' Net Income towards Common Stockholders ranged from a high of $108.5 million in Q3 2025 and a low of -$144.1 million during Q4 2024
- Its 5-year average for Net Income towards Common Stockholders is -$31.1 million, with a median of -$26.4 million in 2022.
- Per our database at Business Quant, IDEAYA Biosciences' Net Income towards Common Stockholders tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
- Quarter analysis of 5 years shows IDEAYA Biosciences' Net Income towards Common Stockholders stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
- Its Net Income towards Common Stockholders was -$94.6 million in Q4 2025, compared to $108.5 million in Q3 2025 and -$144.1 million in Q4 2024.